Format

Send to

Choose Destination
Virus Evol. 2016 Jun 10;2(1):vew014. doi: 10.1093/ve/vew014. eCollection 2016 Jan.

Antiviral drug resistance as an adaptive process.

Author information

1
School of Life Sciences, École Polytechnique Fédéral de Lausanne (EPFL), Lausanne, Switzerland.
2
Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.
3
Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Abstract

Antiviral drug resistance is a matter of great clinical importance that, historically, has been investigated mostly from a virological perspective. Although the proximate mechanisms of resistance can be readily uncovered using these methods, larger evolutionary trends often remain elusive. Recent interest by population geneticists in studies of antiviral resistance has spurred new metrics for evaluating mutation and recombination rates, demographic histories of transmission and compartmentalization, and selective forces incurred during viral adaptation to antiviral drug treatment. We present up-to-date summaries on antiviral resistance for a range of drugs and viral types, and review recent advances for studying their evolutionary histories. We conclude that information imparted by demographic and selective histories, as revealed through population genomic inference, is integral to assessing the evolution of antiviral resistance as it pertains to human health.

KEYWORDS:

antiviral resistance; compensatory mutation; cost of adaptation; fluctuating selection; genetic barrier; mutagenesis

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center